Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2015 Nov 4;11(1):9–25. doi: 10.1007/s11481-015-9637-6

Table 3.

Other staining results following intracranial injection of antibodies

STAIN Anti-GFP Treatment Mean +/− SEM MC-1 Treatment Mean +/− SEM PHF1 Treatment Mean +/− SEM DA9 Treatment Mean +/− SEM
pSer396 1.03 +/− 0.21 0.90 +/− 0.156 0.75 +/− 0.14 1.36 +/− 0.22
CD45 1.06 +/− 0.13 0.96 +/− 0.12 1.13 +/− 0.11 1.06 +/− 0.10

Sub-populations of mice were stained with other phospho-epitopes of tau; here we show an example using pSer396, which did not demonstrate significant reduction in pathology, similar to others tested. Additionally, we examined the microglial marker CD45 to note if antibody treatment had any impact on pro-inflammatory response, which was not reflected here.